Metropolitan Life Insurance Company (MetLife)’s Nautilus Biotechnolgy NAUT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-803	Closed	-$2.4K	–	2332
2023 Q4	$2.4K	Sell	803 -2,326	-74%	-$6.96K	﹤0.01%	2313
2023 Q3	$9.89K	Hold	3,129	–	–	﹤0.01%	2216
2023 Q2	$12.1K	Buy	+3,129	New	+$12.1K	﹤0.01%	2199